Date post: | 15-Dec-2015 |
Category: |
Documents |
Upload: | isabell-hollinger |
View: | 236 times |
Download: | 12 times |
1
WELCOME CENTRAL LEPROSY TEACHING AND
RESEARCH INSTITUTE, TIRUMANI,CHENGALPATTU
HISTORY
1924 Lady Wellington Leprosy Sanatorium at Tirumani
1924 to 1939
Managed by Church of Scotland. Dr. Paul Brand devoted his life for the reconstructive Surgery
1946 Before Independence, Mahatma Gandhi Father of our Nation visited the land of Tirumani. He gave written message of blessing to the patients of the Sanatorium and wished well to the staff.
SIGNATURE AND GREETINGS OF MAHATMA GANDHIJI
Significance of 30th January on 30.01.1946 – Father of the Nation visited CLTRI
Coincidentally, he died on 30.01.1948.
30th January every year celebrated as Anti Leprosy Day.
3
HISTORY
05-01-1955 CLTRI was established by Government of India under a Governing Body
1957- 1966
Dr. Dharmendra famous Leprologist was associated with CLTRI as Director from 1967 to 1971 he was Emeritus Medical Scientist of CLTRI.
Significant Contribution :- Lepromin Test Standardization of DDS (Diamino Diphenyl Sulphone) a drug used for treating leprosy patients.
1967- 1971
1974 CLTRI became a subordinate office of DGHS under MOH&FW
1978-1983 Standardization of MDT (Multi Drug Therapy ) done in this Institute.
1991 Nodal Centre for Thalidoamide drug therapy for ENL (Erythrosom Nodosum Leprosom) reaction Cases.
OBJECTIVE To undertake research into basic problems relating to the occurrence and spread of leprosy and its control.
To train manpower necessary to implement NLEP.
To provide specialized services in the area of diagnosis, reaction, relapse and Reconstructive surgery in Leprosy.
To monitor and evaluate National Leprosy Eradication Programme.
Additional Responsibitiy given in 2005 after Elimination of
LeprosyCBHI TrainingRNTCP Operational ResearchIDSP Training
5
6
AREA OF CLTRI
Total Land of CLTRI - 560.83 Acres
Institutional Buildings - 66.53 Acres
Residential Buildings - 28.72 Acres
Vacant Land - 190.58 Acres
Land Given to HLL (for proposed Mediparkon 20-03-2009 by MOHFW) - 275 Acres
7
BUILDING1.HOSPITAL BLOCK :
Out Patient Unit Main Hospital -124 Bedded Hospital
Sick Room Medical Investigation Ward Surgical Ward with X-ray department & Operation
theatre
Physiotherapy Block MCR and Footwear Unit Centralised Kitchen Laundry Centralised Stores
8
2. ADMINISTRATIVE BLOCK
a. Administration
b. Laboratory & Animal House
c. Library
d. Epidemiology
3. HOSTEL
e. Scientist Hostel - 18 Rooms
f. Students Hostel - 18 Rooms
g. Canteen
BUILDING (Continued)
9
STAFF STRENGTH – STATUS REPORTSl. No. Group Total
Strength Filled Vacancy Vacancy Percentage
1 A ( Medical) Specialist
15 3 12 87%
GDMO 11 6 5 45%
2 A- Non Medical
3 0 3100%
3 B- Gazetted
5 2 360%
4 B- Non-Gazetted
19 14 526%
5 Group C 117 84 33 28%
6 MTS 80 56 24 30%
TOTAL 250 165 85 34%
66 % 34 %
Budget Estimate 2012-13S.No. HEAD PLAN NON-PLAN
10% reduction in Non-plan*
Balance Budget
1 Salaries 0 84150 0 84150
2 Wages 0 1400 0 1400
3 Overtime allowance 0 10 1 9
4 Medical Treatment 0 750 75 675
5 Domestic Travel Expenses 500 300 30 270
6 Office Expenses 2200 2020 202 1818
7 Publication 0 10 1 9
8Other Administrative Expenses 250 0 0 0
9 Supplies and Materials 3500 2800 280 2520
10 Minor Works 1550 0 0 0
11 Scholarships /Stipend 0 300 30 270
12 Other charges 0 10 1 9
13 Motor Vehicles 0 450 45 405
14 Machinery and Equipment 1500 300 30 270
TOTAL 9500 92500 695 91805
11
CLTRI
Clinical
Surgical Epidemiology & Statistics
Laboratory
12
CLINICAL
Out Patient Department
Wards
Nursing Section
Medical Record Section
13
• Expert Management of reactions with
Thalidomide, Relapses/Drug Resistance etc.
• Teaching activities in leprosy to
Undergraduates, House Surgeons of Medical
Colleges, NMS Supervisors and Nurses.
• Collection and study of relapse/recurrence
cases in leprosy.
CLINICAL (Cont.)
14
CLINICAL (Cont.)
On Going research activity
Drug Resistance Surveillance using Mouse foot Pad
15
Out-Patients particulars for the Last 5 years
2008-09 2009-10 2010-11 2011-12
2012-13(Till Oct )
1 No. of newCases
attended OPD
64 104 74 90 48
2 No. of oldCases
attendedOPD
7155 7220 6192 6094 3353
3 No. of patientsattended OPDfrom GLC block
2680 2074 1514 1694 776
4 No. of otherCases (NCL)Attended OPD
2224 1748 1441 1161 775
5 Total no. ofpatients seenin OPD
12123 11146 9221 9039 4952
GLC - Government Leprosy CentreNCL - Not a Case of Leprosy
16
SURGICAL
Surgical Unit
Physiotherapy Section
Artificial Limbs & Footwear Section
X-ray Section
Micro-cellular Rubber
17
Surgical (cont.)
The Basic functions:
• Reconstructive Surgery
• Patient care activities.
• Teaching and Training Programs.
• Research.
18
Physiotherapy SectionPhysiotherapy Services to PAL.
Various Teaching and Training programs.
Counselling & Health Education.
Facilities Available Wax Bath, Electrical Muscle Stimulator, Inter Ferential Therapy, Ultra Sonic Therapy Traction Table.
19
Artificial Limbs & Footwear Section
Footwear and Prosthetic to the Leprosy patients
Micro-cellular Rubber
Small Production unit - Micro-Cellular Rubber sheets (2000 sheets per annum)
Providing MCR sheets to other states
Details of Major and Minor Surgery Done for the Last 5 years
S.No
Surgeries 2007-08 2008-09 2009-10 2010-11 2011-12
Major Surgeries –(Reconstructive Surgery)1. Claw finger correction 7 7 14 6 8
2. Claw thumb correction 3 5 5 5 1
3. Wrist drop Correction - - 1 1 -
4. Drop Foot Correction 5 1 - 6 -
5. Lagapthalmos Correction - 1 2 - -
6.Surgical Decomposition ofNerves (Ulnar Nerve, MedianNerve, Posterior Nerve)
4 1 2 3 -
7.Amputation (Below Knee &Below Elbow Amputation) 4 2 - - -
Minor Surgeries8. Ulcer Surgery 53 16 20 5 -
9.
Miscellaneous like Biopsy, MTHResection, Calcaneal shaving,lagopthalmus, Skin Grafting,Cystectomy etc.
18 4 6 6 -
Physiotherapy Activities for the last 5 year
S.No
Activities 2007-08 2008-09 2009-10 2010-11 2011-12
1. New Case 70 55 77 51 195
2. Assessments
973 895 708 530 789
3. Hand Exercises
1905 1823 1742 1755 1943
4. Foot Exercises
857 797 737 714 749
5. Wax Therapy
1845 1741 1698 1598 1740
6. Splints 460 416 778 309 407
7. General Cases
91 60 67 52 71
Footwear and Prosthetic Supplied for the last 5 year
S.No
2007-08 2008-09 2009-10
2010-11
2011-12
1.
Simple andModified Microcellar RubberSandals (in pairs)
1234 1119 1199 942 500
2.
Orthotic andProsthetic Appliances(in
no’s)
23 21 25 28 5
3.
Major repair ofOrthosis andProsthesis (in
no’s)
8 4 13 12 1
4.
Modifications Arch
Support andMetatarsal Bars (in no’s)
144 115 171 93 54
23
Division of Epidemiology& Statistics
Monitoring &
Evaluation Unit
Statistics
Electronic Data
Processing Unit
Technical Training Library
24
Division of Epidemiology & Statistics
CLTRI Website was created by our unit.
Website for our institute was hosted in NIC server (http://cltri.gov.in/).
Logo for our Institute was designed.
Inventory Management Software was developed.
Consultancy services to the BCGVL, Guindy, Chennai for creation of website and Inventory management system.
Monitoring & Evaluation of NLEP Activities among
Tamil Nadu, Karnataka, Kerala and Lakshawdeepstates/UT was carried out.
Visits Made for Monitoring Activities Lakshadweep Islands - 2000 population of
school children were Examined on January 2012.
Tamil Nadu, Karnataka, Pondicherry States/UT
for planning M & E Activities.
M & E conducted in Erode District, Tamil Nadu.
Monitoring & Evaluation of NLEP Activities
Phase I of the Activity Study of the Household and
Neighbourhood Contacts of newly Reported
Leprosy cases in the CLTRI OPD from
Thirukalukundram Taluk area work was carried
out during October 2011.
Phase II of the Activity is started on August 2012and completed on September 2012
Analysis of the collected data is under process.
Surveillance Activities
SFC proposal for Strengthening of CLTRI was
Prepared and submitted in DGHS (17 Oct 2012).
Operational Research Study to ascertain the
reasons for High Endemicity in 24 districts of 3
states (Andhra Pradesh, Gujarat, Karnataka)
was send to CLD(31 May 2012).
PROPOSALS
OPD Data -New case attending CLTRI OPD for the
past 2 year were entered and analysed.
Spatial Distribution of (Geographical Information) of New cases attending CLTRI was prepared.
Monthly progressive Report from districts of Tamil Nadu, Andhra Pradesh and other states were received and entered into Computerised Simplified Information System (CSIS).
Analysis of Reaction Case data is under process.
Data Analysis
29
Training Activities • State/District Leprosy Officer (SLO/DLO) = 3 batches
(5 days)
• Medical Officer Training Course (5 days) = 2 batches
• Non-Medical Health Supervisor’s (2 months) = 2 batches
• Skin smear Technician Training (5 days) = 1 batch
• Laboratory orientation Training (BCG Staff) = 2 batches
• Final MBBS students (one day visit) =125 students
• CRRI Training (5 days ) =110 Trainees
• Tertiary case management of Leprosy (10 days) = 1 batch
• Inplant training in Microbiology & = 1 batchMolecular Biology to Biotechnology students
30
Library
• Books - 3278
• Journal - 4409
• Periodicals
Foreign journals - 24
Indian Journals - 09
• Dr. V.C.Giri Assistant Director (Epid) attended HIVCONGRESS 2012, Held at Mumbai from 16th to 18th March 2012, Presented one Research paper and Two paper by Co-authors in scientific session.
Attended RTI Act for Public Information Officer training at ISTM, New Delhi –August 2012
Published 2 paper in International Journals.
• Dr. V.C.Giri, AD (Epid) & Dr. R. Veerkumaran, CMO delivered lectures in Leprosy CMC organised by Tirunelveli Medical College, Tirunelveli, Tamil Nadu.
• Mr. U. Aravindan, Statistical Investigator Gr. II attended training in Statistical Analysis system (SAS) training held at Christian Medical College, Vellore, Tamil Nadu.
Workshop/Conference / Training Attended
32
Biochemistry & Animal Hou
se
Sterilisation
Hematology & ImmunologyMicrobiology &
Molecular Biology
Clinical Pathology & Histopathology
LABORATORY
33
LABORATORY (cont.)
Investigation for Leprosy related and other Routine Investigations
Basic and Applied Research activities in Leprosy.
Research in field of Diagnosis, Molecular Biology, Drug therapy, Animal studies in the field of Leprosy etc.,
34
LABORATORY (cont.)
On going Research projects:
Study on surveillance of Drugs [rifampicin
and dapsone] resistance, among smear
positive multibacillary leprosy cases
Detection of fumonisin producing Fusarium
species from rice seeds by polymerase chain
reaction.
Variable number tandem repeats VNTRs
finger printing as an Epidemiological marker
for Mycobacterium leprae haplotyping
35
Laboratory Investigations in the Last 5 years
S.No
DEPARTMENTS / SECTIONS
2008-09
2009-10
2010-11
2011-12
2012-13
1 Clinical Pathology & SkinSmear
1233 1010 831 1168 669
2 Hematology & Serology 2255 3316 3000 3767 1980
3 Microbiology 262 397 100 129 82
4 Histopathology &Molecular biology
(Routine &Research activities)
483 4 71 331
5 Biochemistry 1705 1705 3130 3244 1463
6 Animal Position in theAnimal House1. Balb/C Mice Inbred
Strain 2. Swiss Albino Mice
Inbred Strain3. Rabbit … …
4. Rat … …
5.Sheep
323269
614
323269
614
548496
4
548496
4
548496
4
36
Scientific Publications in last 1 year
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy. Lepr Rev. 2011 Mar;82(1):36-45.
OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian Journal of Medical Microbiology, Vol. 29, No. 3, July-September, 2011, pp. 269-274
Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae. Indian Journal of Medical Microbiology, Vol. 30, Issue 3, 2012, pp. 290-295
blaIMP AND blaVIM Mediated Carbapenem Resistance in Pseudomonas and Acinetobacter species in a Tertiary Care Hospital in India. The Journal of Infection in Developing Countries, October 2012.
37
38
SIGNATURE AND GREETINGS OF MAHATMA GANDHIJI
Phase I:9 cluster are surveyed out of 18 clusters2531 population was Examined 13 Cases case were found. NCDR= 51.36 per 10000
Phase II:9 cluster are surveyed out of 18 clusters3702 population was Examined 13 Cases case were found. NCDR= 35.11 per 10000
Adult Child Total
Paucibacillary (PB) 6 3 9
Multibacillary (MB) 4 0 4
Adult Child Total
Paucibacillary (PB) 6 3 11
Multibacillary (MB) 2 0 2